Prolonged Use of Certain Contraception Jabs may Up Fracture Risk

by Savitha C Muppala on  May 7, 2010 at 8:43 PM Women Health News   - G J E 4
A popular injectible contraceptive, DMPA, is linked with increased risk of bone fracture when used alone, and not in combination with estrogens, a recent insight has revealed.

The study was presented at the World Congress on Osteoporosis (IOF WCO-ECCEO10) in Florence, Italy.
 Prolonged Use of Certain Contraception Jabs may Up Fracture Risk
Prolonged Use of Certain Contraception Jabs may Up Fracture Risk

Depot medroxyprogesterone acetate (DMPA) is a progestin-only long acting reversible hormonal contraceptive birth control drug which is injected every 3 months. It is used by more than 9 million women worldwide, with high usage among teenagers in Europe and the US.

Previous research has shown that use of DMPA is associated with impaired bone acquisition during adolescence and accelerated bone loss later in life, mainly in younger women with lower estrogen levels. However, few studies have looked into the impact of DMPA on fracture risk.

The study, conducted by researchers at the University Hospital Basel, Switzerland and the Boston University Medical Center, Lexington, USA, used a case-control analysis to evaluate the relationship between long-term use of DMPA, with or without estrogen, and the risk of fractures. The results show that in women below 50 years of age, longer-term use of DMPA of two and more years is associated with a 50 percent increased risk of fracture. For users of combined estrogen-containing oral contraceptives fracture risk was not increased.

Source: ANI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like